期刊文献+

白细胞介素-7受体α联合细菌鞭毛蛋白对异基因骨髓移植小鼠急性移植物抗宿主病作用的初步探讨 被引量:1

Preliminary study on IL-7 receptor α combined with bacterial flagellin intervening acute graft-versus-host disease of mice after allogeneic bone marrow transplantation
原文传递
导出
摘要 目的 分析白细胞介素(IL)-7受体α(IL-7Rα)、细菌鞭毛蛋白单用及联合作用于小鼠异基因骨髓移植后急性移植物抗宿主病(aGVHD)模型的疗效,探讨其可能机制.方法 以BALB/C(H-2d)雌性小鼠为受鼠,均接受9 Gy 60Co全身照射,取C57BL/6(H-2b)供鼠骨髓细胞1×107个和脾细胞2×107个经尾静脉输注给受鼠.将受鼠分为单纯照射移植组(A组)、IL-7Rα干预组(B组)、细菌鞭毛蛋白干预组(C组)、IL-7Rα联合细菌鞭毛蛋白干预组(D组),每组6只,观察受鼠的症状、体征、生存时间及造血功能恢复情况.结果 A组小鼠生存期为(22.5±2.30)d,30d生存率为50.0%(3/6), 、且出现明显的倦怠、食欲缺乏、脱毛、弓背等aGVHD表现;B组小鼠生存期为(25.83±3.49)d,30 d生存率为33.3%(2/6),aGVHD表现较A组轻;C组小鼠生存期为(26.33±3.52)d,30 d生存率为33.3%(2/6),亦出现aGVHD表现,程度同B组;D组小鼠生存期为(30.17±2.86)d,30 d生存率为66.7%(4/6),aGVHD表现较前3组轻.4组小鼠外周血白细胞计数均于移植后第7天降至最低,后逐渐恢复,A组较3组干预组恢复慢,B、C两组移植后第14、21、28、30天外周血恢复比较,差异均无统计学意义(均P> 0.05);D组小鼠外周血较B、C组恢复快,差异均有统计学意义(均P< 0.05).4组小鼠移植后第2周CD3+T细胞比例均明显下降,第3周开始逐渐上升,与A组比较,B、C、D3组小鼠CD3+T细胞比例上升明显,B、C两组移植后第2、3、4周比较,差异均无统计学意义(均P> 0.05);D组小鼠较B、C组小鼠T细胞亚群CD3+T细胞恢复快(均P<0.05).结论 通过全身照射能成功建立aGVHD小鼠模型;外源性IL-7Rα、细菌鞭毛蛋白均可减轻aGVHD的发生,两者单用无明显差异,二者联合干预aGVHD小鼠模型与单一干预比较,aGVHD发生更轻,造血恢复会更快. Objective To compare the effects between the impact of IL-7Rα,bacterial flagellin alone to the acute graft-versus-host disease and the combination of both,and to explore its possible mechanism.Methods The BALB/C (H-2d) female mice as recipients were divided into alone irradiation transplantation group (group A),IL-7Rα intervention group (group B),bacterial flagellin intervention group (group C),IL-7Rα combined with bacterial flagellin intervention group (group D),and 6 mice in each group.All mice were accepted 9 Gy 60Co total body irradiation,and 1×107 bone marrow cells and 2× 107 spleen cells of donors C57BL/6 (H-2b) mice were infused via the tail vein to recipient mice.The symptoms,signs,survival time and hematopoietic function recovery of the recipient mice were observed.Results Mice survival of group A was (22.5±2.30) d,30 d survival rate was 50.0 % (3/6),and aGVHD performances inculding the fatigue,anorexia,hair removal,arched,and so on appeared obviously.Survival of group B was (25.83±3.49) d,30 d survival rate was 33.3 % (2/6),aGVHD performances compared with group A was lighter.Survival of group C was (26.33±3.52) d,30 d survival rate was 33.3 % (2/6),also appeared aGVHD performance,which degree was same to the group B.survival of group D was (30.17±2.86) d,30 d survival rate was 66.7 % (4/6),aGVHD performances compared to the other three groups was lightest.The white blood cell count of four groups were reduced to minimum at +7 d,then the three intervention groups gradually recovered.The WBC recovery at 14,21,28,30 day after the transplant of group A compared with slowly was the intervention groups (P 〉 0.05),WBC recovery of B was roughly equal to group C (P 〉 0.05),while the WBC recovery of group D was faster than group B or C (P 〈 0.05).At 2nd week after transplantation,CD3+ T cells was significantly decreased in 4 groups,and at 3rd week began gradually rised.Compared with group A,the proportion of CD3+ cells of other three groups were increased significantly,there was no statistical signifiance of CD3+ cell proportion between group B and group C at 2nd,3rd,4th week after transplantation (P 〉 0.05),while the CD3+ T cell recovery in group D was faster than group B or C (P 〈 0.05).Conclusions The stable aGVHD mouse model was established.Exogenous IL-7Rα and bacterial flagellin may reduce the incidence of aGVHD.There was no significant difference for aGVHD when they was used alone,but when combination of them,aGVHD is slighter and the hematopoietic recorery is faster.
出处 《白血病.淋巴瘤》 CAS 2014年第2期92-95,99,共5页 Journal of Leukemia & Lymphoma
关键词 骨髓移植 移植物抗宿主病 疾病模型 动物 白细胞介素7受体α亚单位 鞭毛蛋白 Bone marrow transplantation Graft vs host disease Disease models, animal Interleukin-7 receptor alpha subunit Flagellin
  • 相关文献

参考文献11

  • 1Gupta V, Ball SE, Sage D, et al. Marrow transplants from matched unrelated donors for aplastic anemia using alemtuzumab, fludarabine and cyclophosphamide based conditioning [J]. Bone Marrow Transplant, 2005, 35:467-471.
  • 2Liu YJ, Wu DP, Li CX, et al. The role of CD4+ CD25+ T cell and FOXP3 in hsot acute graft rejection[J].Zhonghua Nei Ke Za Zhi, 2006, 45: 835-838.
  • 3Thiant S, Shamim Z, Peter L, et al. Impact of donor IL-7R a polymorphism on recipient plasma IL-7 levels and acute gvhd following allogeneie stem cell transplantation[G]//ASH. 52nd Annual Meeting, orlando, 2010.
  • 4Brunkow ME, Jeffery EW, Hjerrild KA, et al. Disruption of a new forkhead winged-helix protein, scurfin, results in the fatal lympho proliferative disorder of the seurfy mouse[J]. Nat Genet, 2001, 27: 68- 73.
  • 5Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+ CD25* regulatory T cells [J]. Nat Immunol, 2003, 4: 330-336.
  • 6卫芬,马梁明,龚旭东,任连生,朱镭,郭慧敏,张华屏.白细胞介素7受体α干预小鼠异基因骨髓移植后急性移植物抗宿主病的初步研究[J].白血病.淋巴瘤,2013,22(2):115-118. 被引量:1
  • 7龚旭东,马梁明,朱镭,郭慧敏,任连生,任瑞瑞,张华屏,卫芬,牛燕燕.TLR5激动剂鞭毛蛋白预防小鼠异基因造血干细胞移植后急性移植物抗宿主病的初步研究[J].中国实验血液学杂志,2012,20(4):965-970. 被引量:5
  • 8Fuller M J, Hildeman DA, Sabbaj S, et al. Cutting edge: emergence of C D 127high functionally competent memory T cells is compromised'by high viral loads and inadequate T cell help[J]. J Immunol, 2005, 174: 5926-5930.
  • 9Burdelya LG, Krivokrysenko VI, Tallant TC, et al. An agonist of toll- like receptor 5 has radioprotective activity in mouse andprimate modoh [J]. Science, 2008, 320: 226-230.
  • 10Vijay-Kumar M, Aitken JD, Sanders C J, et al. Flagellin treatment protects against chemicals, bacteria, viruses, andradiation[J]. Immunol, 2008, 180: 8280-8285.

二级参考文献9

共引文献4

同被引文献10

  • 1柳金,王卉,陆道培.HLA配型不合/单倍型造血干细胞移植供者淋巴细胞输注量与急性移植物抗宿主病的关系[J].中华内科杂志,2007,46(7):578-580. 被引量:2
  • 2黄河.造血干细胞移植并发症的诊断和治疗,/中华医学会,江苏省医学会.2009年华东地区血液学学术会议暨江苏省第十三次血液学学术会议论文集[G],徐州,2009.南京:江苏省医学会,2009:8-11.
  • 3Mo XD, Xu LP, Liu DH, et al. Patients receiving HLA- haploidenfieal/partially matched related allo-HSCT can achieve desirable health related QoL that is comparable to that of patients receiving HLA-identical sibling allo-HSCT [ J ]. Bone Marrow Transplant, 2012, 47 ( 9 ) : 1201-1205. DOI: 10.1038/hint.2011.250.
  • 4Jaksch M, Mattsson J. The pathophysiology of acute graft-versus-host disease [ J ]. Scand J Immunol, 2005, 61 ( 5 ) : 398-409.
  • 5Leventhal J, Huang Y, Xu H, et al. Novel regulatory therapies for prevention of graft-versus-host disease [ J ]. BMC Med, 2012, 10: 48. DOI: 10.1185/1741-7015-10-48.
  • 6Michael M, Shimoni A, Nagler A. Recent compounds for immunosuppression and experimental therapies for acute graft-versus- host disease [ J ]. Isr Med Assoc J, 2013, 15 ( 1 ) : 40-50.
  • 7Hippen KL, Riley JL, June CH, et al. Clinical perspectives for regulatory T ceils in transplantation tolerance [ J ]. Semin Immunol, 2011,23 ( 6 ) : 462-468. DOI: 10.1016/j.smim.2011.07.008.
  • 8Yeung MY, Sayegh MH. Regulatory T cells in transplantation:what we know and what we do not know [ J ]. Transplant Proc, 2009, 41 ( 6 Suppl ) : S21-26. DOI: 10.1016/j.transproceed.2009.06.093.
  • 9张媛,刘晓东,何学鹏,郭智,楼金星,杨凯,陈鹏,刘丹,陈惠仁.供者淋巴细胞输注预防单倍型造血干细胞移植后白血病复发的回顾性分析[J].白血病.淋巴瘤,2011,20(1):26-28. 被引量:7
  • 10郭智,陈惠仁,刘晓东,楼金星,何学鹏,杨凯,陈鹏,张媛.异基因造血干细胞移植治疗复发难治性淋巴瘤的临床研究[J].白血病.淋巴瘤,2013,22(7):423-427. 被引量:11

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部